Column Capital Advisors’s Arcosa ACA Stock Holding History

Column Capital Advisors’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-669	Closed	-$37K	–	704
2020 Q4	$37K	Buy	+669	New	+$34.1K	0.01%	311

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Column Capital Advisors's ACA Position: Q1 2021 in Review

Column Capital Advisors sold out of Arcosa (ACA) in Q1 2021, closing a stake of 669 shares — an estimated $37K sold.

Column Capital Advisors first reported a position in ACA in Q4 2020 and held it in 1 quarter. The position peaked at $37K in Q4 2020. 265 funds tracked by Wall St. Rank hold ACA as of Q1 2021.

Column Capital Advisors reported no remaining Arcosa position as of Q1 2021 after selling out during the quarter.
Column Capital Advisors sold 669 Arcosa shares in Q1 2021, an estimated $37K.
Column Capital Advisors first reported a position in Arcosa in Q4 2020 and held it in 1 quarter.
Column Capital Advisors's Arcosa position peaked at $37K in Q4 2020.
265 funds tracked by Wall St. Rank held Arcosa as of Q1 2021.

Based on Column Capital Advisors's 13F filing for Q1 2021, filed 10 May 2021.